Manufacturers Life Insurance Company, The Biocryst Pharmaceuticals Inc Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 299,152 shares of BCRX stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
299,152
Previous 212,581 40.72%
Holding current value
$2.26 Million
Previous $1.31 Million 73.12%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$6.41 - $8.69 $554,920 - $752,301
86,571 Added 40.72%
299,152 $2.27 Million
Q2 2024

Aug 14, 2024
BUY
$4.13 - $6.79 $467,317 - $768,302
113,152 Added 113.8%
212,581 $1.31 Million
Q1 2024

May 14, 2024
BUY
$4.89 - $7.65 $6,039 - $9,447
1,235 Added 1.26%
99,429 $505,000
Q4 2023

Feb 13, 2024
BUY
$4.98 - $6.77 $951 - $1,293
191 Added 0.19%
98,194 $588,000
Q3 2023

Nov 15, 2023
BUY
$6.71 - $7.92 $141,426 - $166,929
21,077 Added 27.4%
98,003 $693,000
Q2 2023

Aug 11, 2023
BUY
$6.96 - $8.81 $19,787 - $25,046
2,843 Added 3.84%
76,926 $541,000
Q1 2023

May 15, 2023
BUY
$7.94 - $11.84 $2,747 - $4,096
346 Added 0.47%
74,429 $620,000
Q4 2022

Aug 11, 2023
BUY
$10.5 - $14.2 $6,625 - $8,960
631 Added 0.86%
74,083 $850,000
Q4 2022

Feb 13, 2023
BUY
$10.5 - $14.2 $6,625 - $8,960
631 Added 0.86%
74,083 $850,000
Q3 2022

Aug 11, 2023
SELL
$10.79 - $14.81 $13,865 - $19,030
-1,285 Reduced 1.72%
73,452 $925,000
Q3 2022

Nov 03, 2022
SELL
$10.79 - $14.81 $13,865 - $19,030
-1,285 Reduced 1.72%
73,452 $925,000
Q2 2022

Aug 11, 2023
BUY
$7.89 - $17.88 $7,590 - $17,200
962 Added 1.3%
74,737 $790,000
Q2 2022

Aug 15, 2022
BUY
$7.89 - $17.88 $7,590 - $17,200
962 Added 1.3%
74,737 $791,000
Q1 2022

Aug 11, 2023
SELL
$11.56 - $19.76 $7,560 - $12,923
-654 Reduced 0.88%
73,775 $1.2 Million
Q1 2022

May 20, 2022
SELL
$11.56 - $19.76 $195,942 - $334,932
-16,950 Reduced 18.68%
73,775 $1.2 Million
Q4 2021

Feb 16, 2022
BUY
$11.18 - $15.46 $1,542 - $2,133
138 Added 0.15%
90,725 $1.26 Million
Q3 2021

Nov 12, 2021
SELL
$14.21 - $17.65 $126,511 - $157,137
-8,903 Reduced 8.95%
90,587 $1.3 Million
Q2 2021

Aug 12, 2021
BUY
$9.5 - $17.24 $4,047 - $7,344
426 Added 0.43%
99,490 $1.57 Million
Q1 2021

May 03, 2021
SELL
$7.37 - $13.61 $52,238 - $96,467
-7,088 Reduced 6.68%
99,064 $1.01 Million
Q4 2020

Feb 12, 2021
BUY
$3.37 - $8.61 $21,568 - $55,104
6,400 Added 6.42%
106,152 $791,000
Q3 2020

Nov 09, 2020
BUY
$3.43 - $5.53 $25,152 - $40,551
7,333 Added 7.93%
99,752 $343,000
Q2 2020

Aug 10, 2020
SELL
$1.9 - $5.61 $10,888 - $32,150
-5,731 Reduced 5.84%
92,419 $460,000
Q1 2020

May 15, 2020
BUY
$1.6 - $4.11 $43,728 - $112,326
27,330 Added 38.59%
98,150 $196,000
Q4 2019

Feb 14, 2020
SELL
$1.59 - $3.45 $2,310 - $5,012
-1,453 Reduced 2.01%
70,820 $244,000
Q2 2019

Aug 14, 2019
BUY
$2.91 - $9.15 $1,376 - $4,327
473 Added 0.66%
72,273 $274,000
Q1 2019

May 13, 2019
BUY
$7.38 - $9.72 $30,634 - $40,347
4,151 Added 6.14%
71,800 $585,000
Q4 2018

Feb 14, 2019
SELL
$6.51 - $9.6 $36,065 - $53,184
-5,540 Reduced 7.57%
67,649 $546,000
Q3 2018

Nov 14, 2018
SELL
$5.52 - $7.99 $18,547 - $26,846
-3,360 Reduced 4.39%
73,189 $558,000
Q2 2018

Aug 14, 2018
BUY
$4.6 - $6.52 $4,802 - $6,806
1,044 Added 1.38%
76,549 $438,000
Q1 2018

May 15, 2018
SELL
$4.35 - $5.82 $5,376 - $7,193
-1,236 Reduced 1.61%
75,505 $360,000
Q4 2017

Feb 08, 2018
BUY
$4.16 - $5.33 $57,241 - $73,340
13,760 Added 21.85%
76,741 $377,000
Q3 2017

Nov 14, 2017
BUY
$4.1 - $5.97 $258,222 - $375,996
62,981
62,981 $330,000

Others Institutions Holding BCRX

# of Institutions
278
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email